Regeneron Pharmaceuticals, Inc. Stock Hits Short-Term Price Target with 17.79% Profit as Forecasted by QuantWave

Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) has successfully achieved the price target forecast set by QuantWave, an automated forecasting platform, resulting in a profit of 17.79%. The forecast signal was issued on February 11, 2025, with the stock trading at 662.62 USD and predicted to move in a short direction. On April 10, 2025, the target price of 544.76 USD was reached, validating QuantWave's analytics and providing investors with significant gains.